Data presented at the American College of Cardiology Scientific Session suggested that patients taking a class of type 2 diabetes drugs called SGLT2 inhibitors were at lower risk of being hospitalized for heart failure. But that benefit may come at a cost. People with type 2 diabetes are already at risk for various cardiovascular complications. Heart failure is one of the most common, said Mikhail Kosiborod, MD, professor of medicine at the University of Missouri School of Medicine in Kansas City in an interview with Cardiology Today. “Not only that, but it’s arguably the most morbid of (heart related) complications ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.